VentriPoint Diagnostics Ltd. (VPTDF)
USD 0.1
(0.05%)
USD 0.1
(0.05%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 296.98 Thousand CAD | -19.17% |
| 2022 | 367.43 Thousand CAD | 193.06% |
| 2021 | 125.37 Thousand CAD | -90.55% |
| 2020 | 1.32 Million CAD | 52.89% |
| 2019 | 868.03 Thousand CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | -100.0% |
| 2014 | 269.48 Thousand CAD | -69.83% |
| 2013 | 893.29 Thousand CAD | 58.25% |
| 2012 | 564.46 Thousand CAD | -53.58% |
| 2011 | 1.21 Million CAD | -27.4% |
| 2010 | 1.67 Million CAD | 55.17% |
| 2009 | 1.07 Million CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| 2005 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 860.96 Thousand CAD | 1169.77% |
| 2024 Q1 | 276.86 Thousand CAD | -5.69% |
| 2023 Q2 | 330.64 Thousand CAD | -5.72% |
| 2023 FY | 296.98 Thousand CAD | -19.17% |
| 2023 Q4 | 296.98 Thousand CAD | -5.86% |
| 2023 Q3 | 315.48 Thousand CAD | -4.58% |
| 2023 Q1 | 350.69 Thousand CAD | -4.56% |
| 2022 Q1 | 129.37 Thousand CAD | 3.19% |
| 2022 Q4 | 367.43 Thousand CAD | 165.98% |
| 2022 Q2 | 133.62 Thousand CAD | 3.28% |
| 2022 Q3 | 138.14 Thousand CAD | 3.38% |
| 2022 FY | 367.43 Thousand CAD | 193.06% |
| 2021 Q2 | 159.05 Thousand CAD | -7.02% |
| 2021 FY | 125.37 Thousand CAD | -90.55% |
| 2021 Q4 | 125.37 Thousand CAD | -15.51% |
| 2021 Q3 | 148.39 Thousand CAD | -6.71% |
| 2021 Q1 | 171.06 Thousand CAD | -87.11% |
| 2020 Q1 | 1.11 Million CAD | 28.11% |
| 2020 Q4 | 1.32 Million CAD | 45.79% |
| 2020 Q2 | 1.22 Million CAD | 9.79% |
| 2020 FY | 1.32 Million CAD | 52.89% |
| 2020 Q3 | 910.32 Thousand CAD | -25.44% |
| 2019 Q3 | 775.53 Thousand CAD | -14.2% |
| 2019 Q4 | 868.03 Thousand CAD | 11.93% |
| 2019 Q1 | 964.07 Thousand CAD | 0.0% |
| 2019 FY | 868.03 Thousand CAD | 0.0% |
| 2019 Q2 | 903.84 Thousand CAD | -6.25% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2015 Q1 | 302.66 Thousand CAD | 12.31% |
| 2015 Q2 | 343.5 Thousand CAD | 13.49% |
| 2015 Q3 | 306.08 Thousand CAD | -10.89% |
| 2015 FY | - CAD | -100.0% |
| 2015 Q4 | - CAD | -100.0% |
| 2014 Q2 | 342.61 Thousand CAD | -60.11% |
| 2014 Q1 | 858.99 Thousand CAD | -3.84% |
| 2014 FY | 269.48 Thousand CAD | -69.83% |
| 2014 Q4 | 269.48 Thousand CAD | -30.54% |
| 2014 Q3 | 387.97 Thousand CAD | 13.24% |
| 2013 FY | 893.29 Thousand CAD | 58.25% |
| 2013 Q4 | 893.29 Thousand CAD | -35.76% |
| 2013 Q3 | 1.39 Million CAD | -16.81% |
| 2013 Q2 | 1.67 Million CAD | 196.4% |
| 2013 Q1 | 563.94 Thousand CAD | -0.09% |
| 2012 FY | 564.46 Thousand CAD | -53.58% |
| 2012 Q4 | 564.46 Thousand CAD | 1.22% |
| 2012 Q1 | 1.28 Million CAD | 5.76% |
| 2012 Q3 | 557.67 Thousand CAD | 2.33% |
| 2012 Q2 | 544.97 Thousand CAD | -57.62% |
| 2011 Q2 | 1.84 Million CAD | 8.39% |
| 2011 Q4 | 1.21 Million CAD | -32.43% |
| 2011 FY | 1.21 Million CAD | -27.4% |
| 2011 Q1 | 1.7 Million CAD | 1.69% |
| 2011 Q3 | 1.79 Million CAD | -2.52% |
| 2010 Q4 | 1.67 Million CAD | -6.5% |
| 2010 Q3 | 1.79 Million CAD | 6.64% |
| 2010 FY | 1.67 Million CAD | 55.17% |
| 2010 Q2 | 1.67 Million CAD | 64.42% |
| 2010 Q1 | 1.02 Million CAD | -5.35% |
| 2009 FY | 1.07 Million CAD | 0.0% |
| 2009 Q3 | 1.02 Million CAD | 11.79% |
| 2009 Q1 | 496.86 Thousand CAD | 0.0% |
| 2009 Q2 | 917.62 Thousand CAD | 84.68% |
| 2009 Q4 | 1.07 Million CAD | 5.21% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2006 Q4 | - CAD | 0.0% |
| 2006 Q3 | - CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| 2006 Q2 | - CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| IR-Med Inc. | 161 Thousand USD | -84.463% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 12.52 Million USD | 97.63% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -155.903% |
| Polarean Imaging plc | 74.84 Thousand USD | -296.796% |
| Avitar, Inc. | 3.89 Million USD | 92.378% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 33.927% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | 99.905% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | 98.425% |
| Össur hf. | 311.8 Million USD | 99.905% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | 51.944% |
| Escalon Medical Corp. | 279.4 Thousand USD | -6.293% |
| Aurora Spine Corporation | 1.59 Million USD | 81.343% |
| BrainsWay Ltd. | 239 Thousand USD | -24.262% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 16.7 Million USD | 98.222% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | 99.964% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | -36.476% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -579.975% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | 49.663% |
| Nanomix Corporation | 10.11 Million USD | 97.063% |
| Theraclion SA | 1.95 Million EUR | 84.776% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | 2.5% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -97.991% |
| Lombard Medical, Inc. | 28.02 Million USD | 98.94% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | 99.667% |
| Vycor Medical, Inc. | 243.28 Thousand USD | -22.072% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -108.662% |
| SANUWAVE Health, Inc. | 492 Thousand USD | 39.637% |
| VMS Rehab Systems, Inc. | 106.45 USD | -278891.076% |
| Guided Therapeutics, Inc. | 511 Thousand USD | 41.881% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | 44.205% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | 63.061% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | 7.883% |
| Urologix, Inc. | 4.58 Million USD | 93.524% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | 30.971% |
| Nexeon MedSystems Inc. | 2.78 Million USD | 89.341% |
| SS Innovations International, Inc. | 1.91 Million USD | 84.455% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | 99.986% |
| NIOX Group Plc | 500 Thousand USD | 40.603% |
| Fuse Medical, Inc. | 200 Thousand USD | -48.493% |
| Broncus Holding Corporation | 1.22 Million USD | 75.736% |
| Brain Scientific Inc. | 7378.00 USD | -3925.291% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | -83.479% |
| Health Logic Interactive Inc. | - USD | -Infinity% |